M.E

Birla Institute of Technology & Science, Pilani (BITS Pilani) is a Deemed to be University established vide Sec.3 of the UGC Act,1956. It has established itself as a symbol of Excellence and has been declared as an Institution of Eminence (IoE) by the Ministry of Education, Government of India in 2020. It offers Undergraduate, Graduate, and PhD programmes to over 17,000 students across its campuses in Pilani, Dubai, Goa, Hyderabad, and Mumbai.

National Institute of Pharmaceutical Education & Research, Guwahati (NIPER-G) is an autonomous institute of National importance and the first national pharma institute in NE India set up by the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Govt. of India by an act of parliament, to impart high quality Education & Research in the area of Pharmaceutical Sciences.

The Institute intents to fill the following Project positions in various sponsored projects through Online interviews.

AIIMS Jodhpur is one of the SIX NEW AIIMS established by the Ministry of Health & Family Welfare, Government of India under the Pradhan Mantri Swasthya Suraksha Yojna (PMSSY) with the aim of correcting regional imbalances in quality tertiary level healthcare in the country and attaining self sufficiency in graduate and postgraduate medical education. PMSSY planned to set up 6 new AIIMS like institutions in under served areas of the country.

All-India Institute of Medical Sciences was established as an institution of national importance by an Act of Parliament with the objects to develop patterns of teaching in Undergraduate and Post-graduate Medical Education in all its branches so as to demonstrate a high standard of Medical Education in India; to bring together in one place educational facilities of the highest order for the training of personnel in all important branches of health activity; and to attain self-sufficiency in Post-graduate Medical Education.  The Institute has comprehensive f

Biocon is global biopharmaceutical company changing patients lives in over 120 countries by finding new and affordable ways to treat diabetes, cancer and autoimmune diseases. Powered by advanced therapy platforms, our 12,000 plus employees blend heart, science and creativity to make better healthcare solutions. Biocons 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely emerging markets orientation.

The Indian Council of Medical Research (ICMR), New Delhi, the apex body in India for the formulation, coordination and promotion of biomedical research, is one of the oldest medical research bodies in the world.  The ICMR has always attempted to address itself to the growing demands of scientific advances in biomedical research on the one hand, and to the need of finding practical solutions to the health problems of the country, on the other.

Jaypee Institute of Information Technology, Noida was established in the year 2001 and has been declared as a Deemed to be University under Section 3 of UGC Act 1956 in the year 2004.  JIIT’s state-of-the-art, environmentally conditioned campus comprises smart buildings with Wi-Fi connectivity covering the Academic Block, Business School cum Research Block, Faculty Residences, Student Hostels and Annapurna.

National Institute of Pharmaceutical Education and Research (NIPER), Hyderabad is an Institute of National Importance with proclaimed objectives of becoming Centre of Excellence for advanced research in pharmaceutical sciences. NIPER-Mohali was the first institute established in the year 1998 under the aegis of Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, the Govt. of India.

Biocon is global biopharmaceutical company changing patients lives in over 120 countries by finding new and affordable ways to treat diabetes, cancer and autoimmune diseases. Powered by advanced therapy platforms, our 12,000 plus employees blend heart, science and creativity to make better healthcare solutions. Biocons 4 global businesses include generics, biosimilars, research services and novel biologics. They represent Biocon’s risk-balanced strategy, underpinned by agile network connections, a robust pipeline and a timely emerging markets orientation.